Brothers' bid to raise £36,000 as dad battles for his life

Two brothers are aiming to raise £36,000 after their father was diagnosed with pancreatic cancer, hoping to extend his life.

worcesternews.co.uk

mdpi.com

How to tell if muscle pain could be ultra-deadly pancreatic cancer

In his call to action, Dr Bordoloi, who is an internal medicine specialist at Silchar Medical College hospital in India, has offered intriguing detail of the symptoms to watch out for.

dailymail.com

TMPRSS4 Expression Predicts Survival and Benefit from Neoadjuvant Chemotherapy in Pancreatic Cancer - Annals of Surgical Oncology

Background Transmembrane serine protease 4 (TMPRSS4) is known to promote epithelial–mesenchymal transition, invasion, and metastasis in pancreatic cancer and has been linked to chemotherapy resistance...

link.springer.com

LSU LCMC Health cancer center researchers receive $3.1M NIH grant to study pancreatic cancer - The Cancer Letter

LSU Health New Orleans received a five-year, $3.1 million NIH grant to support pancreatic cancer research led by investigators in the LSU LCMC Health Cancer Center. To access this subscriber-only cont...

cancerletter.com

Only 13% survive this cancer. A blood test just detected 90% of early cases

The new blood test detected 90% of early pancreatic cancers, vastly outperforming the standard tumor marker test.

newsweek.com

Family and friends rally round after lorry driver given months to live

Family, friends and colleagues are rallying round a Hampshire lorry driver given three months to live after a pancreatic cancer diagnosis.

hampshirechronicle.co.uk

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer | 2 Minute Medicine

1. Chemotherapy appears to be independently associated with reduced pain severity in advanced pancreatic cancer, reinforcing the importance of routine, longitudinal pain assessment and proactive, indi...

2minutemedicine.com

KRAS on Empty: Lipid Oxidation Blockade Reveals a Metabolic Achilles’ Heel in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in the United States, driven by its aggressive biology and high metastatic incidence at diagnosis. With a 5-year surv...

aacrjournals.org

Spatial Configuration of Pancreatic Cancer Is Associated with Disease Recurrence after Neoadjuvant Therapy and Curative-Intent Resection

Abstract. Purpose: Pancreatic ductal adenocarcinoma (PDAC) frequently recurs after neoadjuvant therapy (NT) and curative-intent resection. Although major pathologic response predicts favorable outcome...

aacrjournals.org

Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk

hopkinsmedicine.org

A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses

After a median follow-up of 16.5 months, none of the participants developed pancreatic cancer, and some of the precancerous lesions shrank or stopped growing.

aacr.org

New Strategy Could Break Pancreatic Cancer’s Protective Shield

A newly identified inflammatory signaling target may help weaken the protective environment surrounding pancreatic tumors and make existing treatments more effective.

scitechdaily.com

Speak Up for Cancer Research: Gary Wight

YouTube video by Huntsman Cancer Institute

youtube.com

Reactivation of DRP1 plays a functional role in resistance to MEK inhibition in pancreatic cancer cells - British Journal of Cancer

British Journal of Cancer - Reactivation of DRP1 plays a functional role in resistance to MEK inhibition in pancreatic cancer cells

nature.com

iomtoday.co.im

Llanegryn turns purple in memory of Heather Black

Llanegryn community honours Heather Black by decorating the village in purple and holding a fundraising event for Pancreatic Cancer UK.

cambrian-news.co.uk

Stealth nanoparticles improve pancreatic cancer treatment with fewer side effects

Pancreatic cancer is considered one of the most lethal cancer because it is often diagnosed late and is difficult to treat.

news-medical.net

SSP for Creon extended for the seventh time amid ongoing supply issues

The SSP for pancreatic enzyme replacement therapy (PERT) medication Creon has been extended due to ongoing supply issues.

thepharmacist.co.uk

<em>KRAS</em> G12D–Mutated Metastatic Pancreatic Cancer: Zoldonrasib Plus Chemotherapy

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown high rates of activity when combined with standard first-line chemotherapy, ...

ascopost.com

Study identifies blood glucose as a key pathway linking obesity to pancreatic cancer risk

iarc.who.int

Tumor heterogeneity: development, mechanisms, and therapeutic implications - Signal Transduction and Targeted Therapy

Signal Transduction and Targeted Therapy - Tumor heterogeneity: development, mechanisms, and therapeutic implications

nature.com

KRAS ctDNA Linked to Worse Overall Survival in Localized Pancreatic Cancer - Oncology Nurse Advisor

Detection of KRAS-mutant ctDNA by both NGS, ddPCR associated with shorter overall survival.

oncologynurseadvisor.com

Pancreatic Collision Tumor Composed of Solid Pseudopapillary Neoplasm and Well-Differentiated Neuroendocrine Tumor: Diagnostic Challenges and Classification Considerations

Collision tumors are uncommon neoplasms composed of two histologically distinct tumor populations occurring within the same anatomic site while maintaining separate boundaries. Pancreatic collision tu...

cureus.com

Blood Test Finds Hidden Pancreatic Cancer After Treatment

A Northwestern Medicine study finds a sensitive blood test detects residual pancreatic cancer missed by standard method.

clpmag.com

Anthropometric Traits and Metabolic Biomarkers Linked to Pancreatic Cancer

A groundbreaking new study published in the British Journal of Cancer sheds light on the intricate relationships between body measurements, metabolic biomarkers, and the risk of developing pancreatic

bioengineer.org

Paolo Tarantino: Measuring Recurrence Rates in HR+/HER2- Breast Cancer - OncoDaily

Paolo Tarantino: Measuring Recurrence Rates in HR+/HER2- Breast Cancer / Breast Cancer, cancer, Erika Hamilton, Fatima Cardoso, Fen Ye, Giuseppe Curigliano,

oncodaily.com

The Big Staffy Stroll! - Weston Park

weston-park.com